Etoricoxib (MK-663; MK-0663)

規(guī)格	庫(kù)存	目錄價(jià)	會(huì)員專享價(jià)	數(shù)量
25 mg	3-5days	￥400.00	登錄后可見(jiàn)	- +
50 mg	3-5days	￥650.00	登錄后可見(jiàn)	- +
100 mg	3-5days	￥850.00	登錄后可見(jiàn)	- +

規(guī)格

庫(kù)存

目錄價(jià)

會(huì)員專享價(jià)

數(shù)量

25 mg

3-5days

￥400.00

登錄后可見(jiàn)

- +

50 mg

3-5days

￥650.00

登錄后可見(jiàn)

- +

100 mg

3-5days

￥850.00

登錄后可見(jiàn)

- +

基本信息

英文名稱	Etoricoxib (MK-663; MK-0663)
中文名稱	依托考昔
CAS號(hào)	202409-33-4
分子式	C18H15ClN2O2S
分子量	358.84
外觀	Light yellow to yellow powder
儲(chǔ)存條件	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

產(chǎn)品詳情

Etoricoxib (also known as MK-0663) is a non-steroidal anti-inflammatory drgu (NSAID) which acts as a selective and orally bioactive COX-2 inhibitor, with IC50s of 1.1 μM and 116 μM for COX-2 and COX-1 in human whole blood. Etoricoxib is a synthetic NSAID with antipyretic, analgesic, and potential antineoplastic properties. Etoricoxib binds specifically to and inhibits the enzyme cyclooxygenase-2 (COX-2), resulting in inhibition of the conversion of arachidonic acid into prostaglandins. Inhibition of COX-2 may induce apoptosis and inhibit tumor cell proliferation and angiogenesis.

相關(guān)文獻(xiàn)

抱歉，暫時(shí)沒(méi)有相關(guān)文獻(xiàn)

相關(guān)產(chǎn)品

抱歉，暫時(shí)沒(méi)有相關(guān)產(chǎn)品

瀏覽記錄

CL1843

依托考昔

202409-33-4 98+% 3-5days

￥400.00 25 mg

久久久无码视频,影音先锋女人av噜噜色,久久久久无码国产精品Sm高潮,人人色综合

依托考昔

Etoricoxib (MK-663; MK-0663)

化學(xué)品安全說(shuō)明書(shū)(MSDS)